Diproteverine

This classification denotes a calcium channel blocker with the molecular formula C26H35NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A5OIA91GT, chemically known as 1-(3,4-diethoxybenzyl)-3,4-dihydro-6,7-diisopropoxyisoquinoline but generally known as diproteverine, which bears US NIH Compound Identifier 50463. European Medicines Agency schedules Diproteverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07227MIG. The term DIPROTEVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). DIPROTEVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diproteverine under HS 29391900 and SITC 54141. As of Q4 2014, DIPROTEVERINE remains the US FDA Preferred Term for this commodity. Diproteverine bears US NLM identifiers UMLS ID C0114311 and NCI Concept Code C73025. SMILES: O(c1cc2c(C(=NCC2)Cc2cc(OCC)c(OCC)cc2)cc1OC(C)C)C(C)C.